Search: Empty
Thank You, HDSA Convention Attendees!
by admin
It was a pleasure to see so many faces, familiar and new, in Atlanta for the 37th Annual HDSA Convention,…
HDBuzz: Can vitamins be used to treat symptoms of HD?
by admin
Researchers in Spain are studying whether a combination of vitamins approved to treat a different brain disorder, biotin-thiamine responsive basal ganglia…
HDBuzz covers newly published research on branaplam
by admin
A study recently published in Nature detailed scientists’ understanding of how branaplam, a drug originally developed for treatment of spinal muscular atrophy…
The Editors of HDBuzz cover the CHDI Therapeutics Conference
by admin
For the first time in two years, scientists, clinicians, and industry partners convened in Palm Springs, CA for CHDI foundation’s 17th Annual HD Therapeutics Conference….
HDBuzz Covers the CHDI Conference
by admin
CHDI is a privately funded HD research foundation whose mission is to further development of HD therapies. This week, they’re hosting…
Raise Awareness of Rare Disease Day with HDSA February 28th
by admin
When you have a rare disease, you face two battles – one being the illness itself, and the other, living…
A new mouse model for HD: The scoop from HDBuzz
by admin
Researchers at UCLA have developed a new mouse model for HD that more closely resembles human HD than ever before….
Splicing Modulators for HD: HDBuzz Covers PTC Therapeutics’ HTT-lowering approach
by admin
Huntingtin lowering (HTT-lowering) has been touted as a promising avenue for treatment of HD because it targets the cause of…
HDBuzz: Oral drug may change the story for huntingtin lowering
by admin
Researchers with PTC Therapeutics recently published exciting new findings – a promising new huntingtin lowering drug that can be taken…
Update from Novartis on Planned Trial of Branaplam for Huntington’s Disease
by admin
Novartis is developing an experimental HD therapy called branaplam which has the potential to lower huntingtin when taken by mouth. Branaplam…
uniQure opens new study sites and changes inclusion criteria for AMT-130 trial
by admin
In a press release published this morning, uniQure announced that AMT-130, an investigational gene therapy for treatment of Huntington’s disease,…
A new Biomarker for HD: HDBuzz on radiolabels for mHTT
by admin
A research team led by Dr. Celia Dominguez at CHDI has identified a new method to track the presence of…
Now Accepting Applications for 2022 Berman-Topper and Donald A. King Research Fellowships
by admin
Earlier this week on November 16, HDSA launched applications for the 2022 cycles of its prestigious Berman-Topper Family HD Career…
Research Wrap-Up: HDBuzz Covers EHDN’s Annual Research Conference
by admin
In September, the European Huntington’s Disease Network brought together scientists and stakeholders from around the world for updates from experts in…
Prilenia Therapeutics and HSG announce completion of participant enrollment in PROOF-HD
by admin
In a recent press release, Prilenia Therapeutics and the Huntington’s Study Group (HSG) announced the completion of participant enrollment in PROOF-HD,…
HD Buzz: Real talk with Roche on GENERATION-HD1
by Kelly Andrew
The editors of HD Buzz recently sat down with leaders from Roche to ask questions on behalf of the HD community…
Roche Regroups: New Partnerships forged in HD Research
by admin
After an unexpected dosing halt in the GENERATION-HD1 study nearly 6 months ago, Roche is gearing up to increase their…
Advances in Gene Therapy: HDBuzz Covers Exciting New Regulatory System, Xon
by admin
Researchers at the Children’s Hospital of Philadelphia have created a system to better regulate gene editing by administration of a secondary activator drug. This novel system, dubbed Xon, acts…
HDBuzz: Creation of a molecular “dimmer switch” advances gene editing
by admin
A new system has been developed that allows researchers to fine-tune gene expression with oral drugs, work that provides a…
HDBuzz on Recent News in the HD Research Pipeline
by admin
The August 9th press release from Voyager Therapeutics left many of us scratching our heads. Luckily, HDBuzz swooped in with their latest…
